



News & Events
SAVE THE DATE!
It is our pleasure to announce that the 14th International VPM Days will take place on Thursday and Friday, 28 and 29 September 2023 at TWINCORE in Hannover, Germany.
NEWS
VPM oversees clinical trial and translational project management – Positive Phase I data of client Memo Therapeutics AG
We are pleased to announce the successful completion of a clinical client project for Memo Therapeutics AG (MTx), Switzerland. The project included a Phase I clinical trial with AntiBKV, an antibody targeting BK polyomavirus (BKV) infection in renal transplant patients. VPM oversaw the clinical trial and performed translational project management, whereas the Australian cooperation partner and contract research organization (CRO) Accelagen managed the trial, yielding positive results, with all endpoints met.
NEWS
VPM oversees clinical trial and translational project management – Positive Phase I data of client Memo Therapeutics AG
Press
Results of SAKK 06/14 trial with VPM1002BC
The phase I/II clinical trial data with VPM1002BC, a genetically modified bacillus Calmette-Guérin (BCG) strain, has been published in European Urology Oncology. Even three years after the treatment start, almost half of the patients remained recurrence-free. We thank all patients, colleagues, and collaborators for their contributions.
A competent partner at your side
Free first consulting session
We understand how complexe product development is, because we did it ourselves. Let us be a competent partner at your side for a secure route to a successful product.
From Bench to Product
Consulting and services
A competent partner at your side
Free first consulting session
From Bench to Product
Consulting and services
Speed up your development processes by using our expertise. We offer a comprehensive service portfolio covering all stages of pharmaceutical development.
About Vakzine Projekt Management
VPM offers tailor-made consultancy and services based on in-depth experience in development of biopharmaceutical candidates. As a client, you will benefit from the experience of our team in translational project management. This enables you to bring your development projects into clinical trials faster, more cost-effectively and with a higher probability of success.
The company was established in 2002. Within the last decade, VPM has successfully managed and consulted the development of promising biopharmaceutical candidates, ranging from small molecules, recombinant proteins up to gene-modified live vaccines and ATMPs. VPM brought these products for its customers in the pharmaceutical industry, academic research and small biotechnology companies, from preclinical phase through clinical phases I-III.
News & Press
SAVE THE DATE!
It is our pleasure to announce that the 14th International VPM Days will take place on Thursday and Friday, 28 and 29 September 2023 at TWINCORE in Hannover, Germany. READ MORE

VPM and training courses
VPM will give lecture for FORUM · Institut für Management GmbH with the title “Risikomanagement in klinischen Prüfungen” The seminar will take place online from August 21-22, 2023 Click here for more information and a 10% discount for participants!

VPM helps facilitate fast track designation for Memo Therapeutics AG’s AntiBKV first-in-class treatment for BK virus infection in renal transplant recipients
Vakzine Projekt Management GmbH (VPM) announced today that it has supported Memo Therapeutics AG (MTx) during the process for receiving fast track designation from the U.S. Food and Drug Administration (FDA) for the novel human monoclonal antibody, AntiBKV, developed by MTx for the treatment of BK viremia in kidney transplant recipients. READ MORE





